ADVANCED SOLID TUMORS
Clinical trials for ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo takes on advanced cancers in early trial
Disease control OngoingThis early-phase study tests an experimental drug called AMG 355, given alone or with another cancer drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated May 01, 2026 15:43 UTC
-
New pill targets hard-to-treat cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new drug called GDC-6036 in people with advanced cancers (like lung or colon cancer) that have a specific KRAS G12C mutation. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors when used alone or with other c…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 01, 2026 15:42 UTC
-
New hope for advanced cancers: drug shows promise in shrinking tumors
Disease control OngoingThis study tests a drug called pembrolizumab in about 1,600 people with advanced solid tumors (like anal, bile duct, or endometrial cancer) that have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the tumors. Participants receive p…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 01, 2026 15:38 UTC
-
New drug ZW191 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage study tests a new drug called ZW191 in about 145 people with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancers. The drug is designed to deliver a cancer-killing agent directly to cells that have a specific marker (folate recep…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Zymeworks BC Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control OngoingThis study tests a drug called sotorasib, alone or with other cancer treatments, in adults with advanced solid tumors that have a specific KRAS G12C gene mutation. The main goals are to check safety and how well the drug works at shrinking or controlling tumors. About 610 partici…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New drug combo aims to reawaken immune cells against tough cancers
Disease control OngoingThis study tests a new drug, ASP1570, in adults with advanced solid tumors that have not responded to standard treatments. The drug is given alone or with other cancer therapies to see if it can help the immune system fight the cancer. The main goals are to check safety and find …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New drug targets tough cancers with KRAS G12V mutation
Disease control OngoingThis early-phase study tests a new drug, QTX3544, in people with advanced solid tumors that have a specific genetic mutation called KRAS G12V. The main goals are to check the drug's safety and how well it works, either alone or with another drug called cetuximab. About 237 partic…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Quanta Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
First human trial of PRL3-ZUMAB aims to find safe dose for advanced cancers
Disease control OngoingThis study tests the safety of a new drug, PRL3-ZUMAB, in people with advanced solid tumors that have not responded to standard treatments. It is the first time this drug is given to humans, after showing good tolerance in animals. The main goal is to find the safest dose and che…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC